Recipients › North Carolina › Collaborations Pharmaceuticals, Inc.
Recipient organisation · UEI EFJCLL37KKH3
Collaborations Pharmaceuticals, Inc.
USAspending caveat. Figures are obligations reported by federal agencies to USAspending.gov, not payments. In USAspending's words: "An outlay occurs when federal money is actually paid out, not just promised to be paid ('obligated')." "Every agency has a Senior Accountable Official who must officially certify that the quarterly financial data submitted by their agency is accurate and complete." "If there are any discrepancies in procurement data, FPDS is the authoritative source." Contract data for the Department of Defense and the U.S. Army Corps of Engineers is published with a 90-day delay. Data loaded 30 Sep 2026. View the USAspending recipient profile.
Federal agencies obligated $13M to Collaborations Pharmaceuticals, Inc., Fuquay Varina, NC, in the listed fiscal years 2023, 2024, 2025.
Collaborations Pharmaceuticals, Inc. ranks 522 of 650 listed organisations located in NC by five-year obligations, and 23,961 of 30,989 nationally.
Its $1.0M-plus awards since FY2023 came from Department of Health and Human Services: 3 awards worth $8.0M in total award value.
Its largest contract industry is NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)), where it ranks 147 of 174 organisations by the value of $1.0M-plus awards.
Obligations by fiscal year contracts vs assistance
| Fiscal year | All obligations | Contracts | Assistance | Change |
|---|---|---|---|---|
| FY2023 | $3,849,886 | under $1.0M | $3,849,886 | — |
| FY2024 | $2,941,558 | under $1.0M | $2,941,558 | -24% |
| FY2025 | $5,786,960 | $1,999,195 | $3,787,765 | +97% |
| FY2026 | under $1.0M | — | — | — |
| FY2027 to date | under $1.0M | — | — | — |
A fiscal year runs 1 October to 30 September. "Contracts" are procurement award types A–D; "assistance" is everything else (grants, direct payments, loan subsidy cost, insurance, other). The contracts column is listed only where contract obligations alone reached $1.0M; the assistance figure is the remainder and may therefore include up to $1.0M of contracts.
Compared with its state and the largest recipients five listed years
| Measure | This organisation | Largest in NC | Largest nationally |
|---|---|---|---|
| Five-year obligations (listed years) | $13M | $114B | $416B |
| FY2026 obligations | under $1.0M | $33B | $118B |
| Contracts, five years | $2.0M | $4.9M | $94B |
| Assistance, five years | $11M | $114B | $416B |
| Rank by five-year obligations | 23,961 of 30,989 | 1 of 650 in NC | 1 |
Largest in state: North Carolina Department of Health & Human Services. Largest nationally: Health Care Services, California Department of. Rankings count organisations located in the state, by the sum of their listed fiscal years.
Awarding agencies $1.0M+ awards since FY2023
| # | Agency | Awards | Award value | Share |
|---|---|---|---|---|
| 1 | Department of Health and Human Services | 3 | $8.0M | 100% |
Contract industries NAICS
Rank within NAICS 541714: 147 of 174 organisations by $1.0M+ award value; see Research and Development in Biotechnology (except Nanobiotechnology).
Assistance programs listings
Places of performance $1.0M+ awards
Counties: Wake County, NC $8.0M
Largest awards begun since FY2023
| Awarding agency | Type | Industry or program | Award value | Begun | Place | Record |
|---|---|---|---|---|---|---|
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders | $4.0M | 7 Mar 2024 | NC | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.113 Environmental Health | $2.0M | 4 Sep 2024 | NC | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | ContractDefinitive Contract | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $2.0M | 29 Sep 2025 | NC | USAspending |
Award value is the amount obligated to the award to date as USAspending reports it. Descriptions below are USAspending's text, unedited and truncated; those that appear to name a person are withheld.
- $4.0M, Department of Health and Human Services, 7 Mar 2024: MANUFACTURE OF AN INTRACEREBROVENTRICULAR ENZYME REPLACEMENT THERAPY FOR CLN1 BATTEN DISEASE - SUMMARY THE NEURONAL CEROID LIPOFUSCINOSES (NCLS) ARE A GROUP OF
- $2.0M, Department of Health and Human Services, 4 Sep 2024: MACHINE LEARNING APPROACHES TO PREDICT ACETYLCHOLINESTERASE INHIBITION AND MODEL APPLICATIONS - SUMMARY ORGANOPHOSPHORUS (OP) COMPOUNDS ARE ONE OF THE MOST COMM
- $2.0M, Department of Health and Human Services, 29 Sep 2025: IS TO DEVELOP PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICATION COMPLEX BY DEMONSTRATING PYRONARIDINE AS A VIABLE SINGLE DOSE TR
Questions and answers
How much federal money does Collaborations Pharmaceuticals, Inc. receive?
$13M in award obligations over the fiscal years it is listed for (FY2023: $3.8M; FY2024: $2.9M; FY2025: $5.8M). Years not listed were under the $1.0M floor. Obligations are binding commitments, not payments made.
Which agencies award to Collaborations Pharmaceuticals, Inc.?
By the value of $1.0M-plus awards begun since FY2023: Department of Health and Human Services ($8.0M).
What is the money for?
Contracts are classified under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology). Assistance falls under Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853) and Environmental Health (93.113).
Where is the work performed?
Primary places of performance for its larger awards: NC ($8.0M).
Is Collaborations Pharmaceuticals, Inc. a large federal recipient?
It ranks 23,961 of 30,989 organisations on this site by five-year obligations and 522 of 650 located in NC. The site covers organisations with at least $1.0M in a fiscal year; individuals are excluded.
Where does this data come from?
USAspending.gov (U.S. Treasury), award transactions as loaded on 30 Sep 2026; fiscal-year totals via the spending-by-category endpoint and award lists via the award search endpoint. The USAspending recipient profile is the authoritative record.
Provenance
Source: USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service), CC0. Fiscal-year obligations from the spending-by-category recipient ranking by recipient state (listing floor $1.0M per year); awards from the award search endpoint (new awards of $1.0M or more by base obligation date); parent and business categories from the recipient profile where fetched. Closed fiscal years are snapshots taken after year end; FY2027 is refreshed on each build. Data loaded by USAspending on 30 Sep 2026. Individuals and sole proprietors are excluded at ingest. Errors in processing are corrected at the next build; see corrections and the methodology.